UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 14A
                PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                            (AMENDMENT NO.         )

Filed by the Registrant [  ]
Filed by a Party other than the Registrant [X ]
Check the appropriate box:

[  ]     Preliminary Proxy Statement

[  ]     CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE
         14A-6(E)(2))

[X ]     Definitive Proxy Statement

[  ]     Definitive Additional Materials

[  ]     Soliciting Material Pursuant to  240.14a-12


                         COMPETITIVE TECHNOLOGIES, INC.
                (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                   THE COMMITTEE TO RESTORE STOCKHOLDER VALUE
    (NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT)

Payment of Filing Fee (Check the appropriate box):

[X ]    No fee required.

[  ]    Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

     (1)     Title of each class of securities to which transaction applies:

     (2)     Aggregate number of securities to which transaction applies:

     (3)     Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):

     (4)     Proposed maximum aggregate value of transaction:

     (5)     Total fee paid:

[  ]     Fee paid previously with preliminary materials.

[  ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.

     (1)     Amount Previously Paid:

     (2)     Form, Schedule or Registration Statement No.:

     (3)     Filing Party:


     (4)     Date Filed:




                    THE COMMITTEE TO RESTORE STOCKHOLDER VALUE

                         ______________________________

                              PROXY SOLICITATION IN
                      OPPOSITION TO THE BOARD OF DIRECTORS
                        OF COMPETITIVE TECHNOLOGIES, INC.
                         ______________________________

                                                               DECEMBER 18, 2006

     This  Proxy  Statement,  the  accompanying  letter  to stockholders and the
enclosed BLUE proxy card are being furnished to the holders of Common Stock, par
value  $0.01  per  share,  of  Competitive  Technologies,  Inc.  ("Competitive
Technologies"  or  the  "Company"),  777  Commerce  Drive, Suite 100, Fairfield,
Connecticut  06825,  in  connection with the solicitation of BLUE proxies by THE
COMMITTEE  TO RESTORE STOCKHOLDER VALUE (the "Committee").  This Proxy Statement
will  first  be  delivered  to  Competitive  Technology Stockholders on or about
December  18,  2006.

     The  Committee  is  comprised of the former Chief Executive of the Company,
John  Nano, as well as Ben Marcovitch, William L. Reali and Richard D. Hornidge,
Jr.  Specific information with respect to each of these members of the Committee
is  set  forth  below  under  "Nominees  for  Election  as  Directors."

     The  BLUE  proxies  are  for  use  at the Annual Meeting of Stockholders of
Competitive  Technologies  scheduled for Tuesday, January 16, 2007 at 10:00 a.m.
local  time at the American Stock Exchange, 86 Trinity Place, New York, New York
10006  (the "Annual Meeting"), and at any adjournments or postponements thereof.
THIS  SOLICITATION IS BEING MADE ON BEHALF OF THE COMMITTEE AND NOT ON BEHALF OF
THE  BOARD  OF  DIRECTORS  OF  COMPETITIVE  TECHNOLOGIES.

     John  Nano  was  Chief  Executive  Officer  and  President  of  Competitive
Technologies  from  2002  to  2005. During that period, John's team relentlessly
identified  growth  opportunities  that  drove  profitability  and value for our
stockholders.  Those  efforts  succeeded  as  earnings  rose $9.7 million over a
period  of three years.  John's management team achieved three consecutive years
of  significant profit improvements, reaching $5.7 million in fiscal 2005.  That
record  revenue  and  profit growth resulted in the Company being the fourteenth
largest  percentage gaining stock in 2004 as reported by the Wall Street Journal
with  an  increase  share  price  of  345%.




     The  current  directors  removed  John  Nano  seventeen  months  ago  for
inappropriate  reasons  discussed  below.  Since  then  stockholder  value  has
continually  been  squandered  even  as  the  overall  stock  market performs at
record-levels.  In  the recently announced fiscal year 2006 results, Competitive
Technologies revenues were reduced by nearly $9.0 million (or 63%), and earnings
by  $8.1  million under the Company's current Board and management.  The current
Board  and  management  presided  over  a  reversal  of Competitive Technology's
fortunes from a 2005 profit of about $5.7 million, to a 2006 loss of nearly $2.4
million  this  year.  The  $8.1  million  reversal  under  the current Board and
management,  from  strong profitability to appalling losses, had the predictable
effect  of  cratering  your  stock  price.  The  existing Board of Directors and
management  of Competitive Technologies have recorded losses every quarter after
they  changed  management.

     The  Committee  has  nominated a slate of six directors for election at the
Annual  Meeting.  The  shares  represented  by each BLUE proxy which is properly
executed  and  returned  to the Committee will be voted at the Annual Meeting in
accordance  with  the  instructions  marked thereon.  Executed but unmarked BLUE
proxies will be voted for the Committee's nominees and, at the discretion of the
persons  named  as  proxies, upon such other matters as may properly come before
the  meeting.

     The  enclosed  form  of  BLUE proxy may only be executed by stockholders of
record at the close of business on November 20, 2006 (the "Record Date").  There
were  8,009,380  shares  of  common  stock, $0.01 par value ("Common Stock") and
2,427  outstanding  shares  of  5%  preferred  stock,  $25 par value ("Preferred
Stock")  outstanding  as  of  November  20,  2006,  according  to  Competitive
Technology's  Proxy  Statement  filed on December 4, 2006.  Each share of Common
Stock  or  Preferred  Stock  outstanding  on the Record Date entitles the record
holder  thereof  to cast one vote.  Business may only be transacted at a meeting
of  stockholders  if a quorum is present at the meeting.  Such a quorum consists
of  a  majority  of  the  outstanding  shares  entitled  to  vote at the meeting
represented  in  person or by proxy.  The affirmative vote of a plurality of the
holders  of  Competitive  Technologies'  outstanding  Common Stock and Preferred
Stock  represented  and  voting  at  the  Annual  Meeting  is  required to elect
directors,  and  a  vote  of  a majority of such holders is required to take all
other  action  to  be  considered  at  the  Annual  Meeting.

     Any  stockholder  granting  a  proxy may revoke it at any time before it is
voted  by executing a new proxy bearing a later date, by voting in person at the
Annual  Meeting  or  by giving written notice of revocation to the Committee c/o
Cutler  Law Group, 3206 West Wimbledon Drive, Augusta, GA 30909; facsimile (706)
738-1966.




     If you hold your shares in "street name" or as a beneficial owner (in other
words your shares are held in a brokerage account and you do not physically hold
a  stock  certificate),  you  must advise your broker or nominee how to vote the
shares  in  writing.  Please advise us and we will forward to your broker a form
of  BLUE  proxy.  We  will  also  pay  the  reasonable  costs  of such broker in
obtaining your proxy.  If you wish to vote in person or at the meeting, you will
need  to  obtain from your broker (the record holder) and bring to the meeting a
BLUE  proxy  signed by the record holder identifying you as the beneficial owner
of  the  shares  and  giving  you  the  right to vote the shares at the meeting.

     If  you  have  already  executed  and  returned a proxy card to Competitive
Technologies,  the  Committee  urges  you  to  revoke  it by signing, dating and
returning  the  BLUE  proxy  card  in  the  enclosed  envelope.

     Remember,  only  your  latest  dated  proxy  counts.

     YOUR  VOTE  IS  IMPORTANT.  PLEASE  SIGN  AND  DATE THE BLUE PROXY CARD AND
RETURN  IT  PROMPTLY IN THE ENCLOSED ENVELOPE.  IF YOU NEED ASSISTANCE IN VOTING
YOUR SHARES, PLEASE CONTACT: JOHN DEREK ELWIN III;  PHONE NUMBER: (561) 789-6449

                   THE COMMITTEE TO RESTORE STOCKHOLDER VALUE

                              c/o Cutler Law Group
                            3206 West Wimbledon Drive
                                Augusta, GA 30909



                          REASONS FOR THE SOLICITATION

     As  a  stockholder  of Competitive Technologies, you should be aware of the
following  significant  events  that  have  occurred  during  the past seventeen
months,  after  removal of John Nano, which we believe reflect the deteriorating
economic  condition  of  the  Company:

     The  Company  has gone from strong profitability of $5.7 million for fiscal
year  2005  to appalling losses of $2.4 million for fiscal year 2006.  The stock
price  has  gone  from  over $10 per share to under $3 per share during the past
seventeen  months.

     The existing Board of Directors and their management have failed to produce
new significant royalty streams to replace the homocysteine royalty stream which
will  end  with  the  patent  expiration  in July 2007.   Last year homocysteine
royalties  accounted for approximately 70% of Competitive Technologies' revenue.

     The  existing  Board  of  Directors and their management have unnecessarily
diluted the outstanding common stock, with the impact of directly and needlessly
reducing  the  market price, by continuing to sell newly issued shares to Fusion
Capital Fund II, LLC, even though our management team left the Company with over
$13  million  in  cash  and zero long-term debt.  During this extremely dilutive
issuance,  our Company's stock price declined from over $6 per share to under $3
per  share.

     The  existing  Board  of  Directors  and  their management have compensated
themselves  with  increased salaries, bonuses and stock options while their lack
of performance has caused substantial losses in earnings, revenue declines and a
major  drop  in  the market value of  Competitive Technologies.  As set forth in
their  proxy  statement,  Mr.  Freed,  Mr.  Kiley  and Mr. Davidson-the existing
management team-received total compensation of $1,303,980.  Does that sound like
good  use of stockholder funds in a Company which continues to lose value in the
stock  market?  Mr. Freed's compensation package alone has gone from $244,847 in
2004  to  $456,470  in  2006.

     The  existing Board of Directors and their management have refused to honor
the  employment  contract of John Nano, the former President and Chief Executive
Officer,  and  instead  wasted significant Company funds on legal fees.  John, a
key  member of the Committee, had led the Company to record revenues and profits
resulting  in  the Company being the fourteenth largest percentage gaining stock
in  2004  on the NYSE, NASD or AMEX as reported by the Wall Street Journal.  Mr.
John  Nano  was terminated seventeen months ago by this Board because HE REFUSED
TO  SIGN  THE  CERTIFICATION  REQUIRED  UNDER  THE  SARBANES-OXLEY  ACT  UNLESS
ALLEGATIONS  OF INSIDER TRADING AND SIMILAR ACTS BY BOARD MEMBERS WERE CURED AND
FULLY  DISCLOSED  TO  THE  STOCKHOLDERS.




     The  existing Board of Directors and their management have refused to honor
the  compensation  agreements of a Senior Vice President, and the Vice President
and  General  Counsel.  Through their efforts, these two employees were directly
responsible  for  generating  more  revenue  than  all  of  the  other employees
combined.  Instead  of  rewarding  performance,  this Board and their management
have  again  elected  to  spend  Company  funds  on  legal  fees

     The  existing  Board  of Directors and their management spent Company funds
and  management  resources  to  file a lawsuit against a fellow stockholder that
spoke  his  mind  on  a  stockholder  internet  message  board about the current
management's  lack  of  performance.  The  unacceptable  results  of the Company
validate  the  concerns  of this disclosing stockholder.  This Board and current
management  should  use  the Company's valuable resources of money and people to
generate  new  revenue  and  not  wasted  on  non-productive  legal  fees.

     After  several  years  with the Company the existing Board of Directors and
their management only own a total of 156,430 shares, which is approximately 1.9%
of  the  outstanding  stock.

     Michael  Kiley,  who  had  been  Competitive  Technologies  Executive  Vice
President  and  Chief  Operating  Officer,  resigned  on November 27, 2006 after
having  only  served  as COO of the Company since August 25, 2005.  What makes a
COO quit after only a year on the job when he had a salary of $225,000 and other
compensation  totaling  $322,670?  Why  was  Mr.  Kiley  then given a consulting
contract  with  a  minimum  guarantee  of  $20,000 per month plus expenses after
questionable  performance  with  the  Company?

     The  existing  Board of Directors have refused to replace directors despite
widespread  stockholder  dissent  and  concerns.

     We  strongly  believe  these  serious  issues  demonstrate  the  continued
unacceptable  performance  of  this  Board  and their management and substantial
failures  in  their  fiduciary  responsibilities  to  Competitive  Technologies
stockholders.  We  therefore  request your support in replacing the entire Board
of  Directors  to  return  Competitive  Technologies  to  the  attractive growth
business  that  we  had  achieved  as  recently  as  2005.




                THE COMMITTEE'S PLAN FOR COMPETITIVE TECHNOLOGIES

     To restore our Company's profitability and stockholder value, we are firmly
committed  to the replacement of the entire Board of Directors and return of our
successful  management  team.  Our  team  urgently  asks  for  your support as a
stockholder, advisor or broker to restore the Company to profitability, to drive
growth  and  to  increase  stockholder  value.

     For  our  fellow stockholders, the Committee has a planned, strategic focus
for  the  future  turnaround  and  success of Competitive Technologies.  We will
aggressively  leverage  near-term  opportunities while executing our longer-term
strategy  for  sustained  growth.

     As  many of you are aware and as more fully set forth below, our management
team  has a proven track record through its previously successful transformation
of  Competitive  Technologies.  Under  the  leadership  of  John  B.  Nano,  our
management  delivered  on  its  commitment  to  drive  revenue  growth,  improve
profitability and strengthen the balance sheet which significantly increased the
stockholder  value of the Company (as measured in market price) during the three
year  fiscal  period  ending in 2005.  During that period, implementation of our
management's successful strategy resulted in revenue growth of 546% and a profit
increase  of  $9.7  million,  from  a $4.0 million loss in fiscal 2002 to a $5.7
million  profit  in  fiscal 2005.  Cash on the debt-free balance sheet reached a
level  of  $14.3  million,  and  Competitive Technologies' market capitalization
increased  significantly  from  approximately  $10  million to in excess of $100
million  in 2005.  Our strategic implementation of management's plans drove this
success  during  a  challenging  business  environment  and a difficult economy.

     The  Committee's  plan  is to generate profitable growth by focusing on the
attractive  global  market  opportunities for innovative technologies to license
and  commercialize.  Through  our  management team, we will continue to focus on
the  core  strategy  for  the  attractive,  high return on investment, licensing
business  model.  In  addition,  our  management  will  target  and  exploit
commercialization  opportunities  that offer accelerated growth though strategic
partnerships  and  relationships.

     All  the  key  market  drivers  for our technology licensing business model
continue  to  be  favorable  and  include:

     An  increased  number  of  new  patents  available  which creates licensing
     opportunities  to  fill  market  needs

     Utilization  of  licensing  with  a substantial reduction in time to market
     which  provides  significant  competitive  advantages

     The  comparative  high  cost  of  internal research and product development
     compared  to  licensing




     The  licensing  market  is  attractive in size and growth with major global
companies spending billions in licensing fees annually.  Last year, Samsung paid
approximately  $1.5  billion  in  licensing  fees and LG paid approximately $1.0
billion  in licensing fees.  Companies like Qualcomm receive millions of dollars
per  year  in  licensing fees creating a market value for Qualcomm stock of over
$60  billion.  Successful  licensing  companies like Qualcomm, IBM and Microsoft
validate  the  attractiveness  of  this  business  model  for companies that can
execute.  The  Committee's  management team has a proven track record of success
in  the licensing business and plans to aggressively exploit near-term licensing
opportunities  currently  available.

     In  addition  to  our  core  licensing  business,  the  Committee  plans to
accelerate  growth by targeting selected commercialization opportunities that we
will  capitalize on though strategic partnerships and relationships.  Two large,
profitable  and attractive global markets have been specifically targeted by our
experienced  management.  Both  of  these  opportunities  require  innovative
technologies to fulfill unmet needs in the marketplace.  Our management team can
provide  those  technologies.

     One  area  of  business  opportunity  we  have targeted is in the large and
profitable pharmaceutical market.  The Committee's management team has potential
access  to  a  portfolio of innovative technologies that could fill unmet market
needs  such  as  safely  reducing  cholesterol  levels,  lowering  hypertension,
suppressing  appetite  and  other  similar  needs.  In addition to our potential
source  for  these  desirable  technologies,  a  major  Asian  partner  we  have
identified  could  provide commercial distribution for these technologies in the
near-term.

     Another  area  of  business  opportunity  we  have  selected  for  the  new
Competitive  Technologies  after our successful re-election to management is the
growing  need  for  alternative  energy sources.  For example, we have potential
access to patented technologies that could fill an unmet market need for greater
cost effectiveness in solar panels.  This portfolio of patented technologies has
the  potential  to  reduce  the cost to manufacture solar panels and enables the
conversion  of  solar energy to electricity more efficiently.  Demand for energy
continues  to  grow  globally  driving  the  opportunities  for this potentially
valuable  patent  portfolio  in  the  near-term.

     The  Committee's management team has successfully demonstrated this ability
to  create  and  implement  strategic plans that generate revenue and profitable
growth  for both the near-term and longer-term at Competitive Technologies.  Our
experienced  management  is  uniquely  qualified to capitalize on the attractive
market opportunities currently available to increase stockholder value again and
provide  a  bright  future  for  the  Company.

     Your  support  is  urgently  needed  by  sending  us  your  BLUE  proxy and
consequently  electing  our  slate  of  Directors, which gives us the ability to
unlock  the potential in Competitive Technologies and restore stockholder value.




                       NOMINEES FOR ELECTION AS DIRECTORS

     Competitive  Technologies'  Board  of  Directors  currently consists of six
members.  Each  director elected at the meeting will have a term expiring at the
2008  annual  meeting of stockholders or until his successor is duly elected and
qualified.

     The Committee has nominated John B. Nano, Ben Marcovitch, William L. Reali,
Joel  M. Evans, MD., Richard D. Hornidge, Jr. and Ralph S. Torello to be elected
by stockholders to the Company's Board of Directors at the Annual Meeting.  Each
of these nominees has consented to serve as a director if elected, and it is not
contemplated  that  any  of  the  nominees will be unavailable for election as a
director.  If any of these nominees should for any reason fail to be a candidate
for  election  as  a  director  at  the Annual Meeting, the persons named on the
enclosed  BLUE  proxy  will  vote  for  a  substitute  nominee  selected  by the
Committee.

     None  of the nominees of the Committee has, during the past ten years, been
convicted  in any criminal proceeding.  Except with respect to Mr. Nano who will
be  appointed  as President and Chief Executive Officer, none of the nominees of
the  Committee  have any arrangement or understanding with respect to any future
employment  with  Competitive Technologies or its affiliates, or with respect to
any future transactions to which Competitive Technologies or its affiliates will
or  may  be  a  party.

     After the nominees are elected directors, the nominees intend to buy shares
in  the  company to further align their interests with fellow shareholders.  The
following  information  is provided with respect to the Committee's nominees for
directors  of  Competitive  Technologies:

     JOHN  B. NANO, 62, the President and Chief Executive Officer who was forced
out  seventeen  months ago by the Board, would return as Director, President and
Chief  Executive Officer.  Mr. Nano was President and Chief Executive Officer of
Competitive  Technologies,  Inc.  from  June  2002  until  June 2005.  Since his
removal  by  the  existing  Board, in January 2006 Mr. Nano become President and
Chief Executive Officer of Articulated Technologies, LLC., a company involved in
creating  and  commercializing  patented  light  emitting diode technologies for
global  solid  state  lighting  applications.  Mr.  Nano  also  served  as Chief
Financial  Officer  of  Competitive  Technologies  from August 2003 to May 2004.
From  2000  to  2001,  he  served  as  a  Principal reporting to the Chairman of
Stonehenge  Network  Holdings,  N.V., a global virtual private network provider,
with  respect  to  certain  operating, strategic planning and finance functions.
From  1998  to  1999,  Mr.  Nano  served  as  Executive Vice President and Chief
Financial  Officer  of ConAgra Trade Group, Inc., a subsidiary of ConAgra, Inc.,
an  international  food company.  From 1993 to 1998, he served as Executive Vice
President  and  Chief  Financial  Officer  of  Sunkyong  America,  the  American
subsidiary  of  the  Sunkyong  Group, a Korean conglomerate, and President of an



Internet  Startup  Division  of  Sunkyong  America.  Mr.  Nano owns 22 shares of
Competitive  Technologies,  Inc.  stock  and  has  an  option to purchase 75,000
additional  shares  which is presently disputed by the Company. After the change
in  management,  Mr.  Nano intends to buy additional shares in the company as he
previously  did  when  he  was  President  and  Chief  Executive  Officer.

     As  more  fully  set  forth  below  under "Certain Litigation", Mr. Nano is
involved  in  litigation  pending  against  the  Company  in connection with his
previous  employment  agreement  with  the  Company  and  wrongful  termination.
Returning  Mr. Nano to his very successful role as President and Chief Executive
Officer  will  resolve  this  costly  outstanding  litigation.

     BEN  MARCOVITCH,  72,  will  be  elected as a Director of the Company.  Mr.
Marcovitch  has  over  50  years  of  in-depth  experience in corporate finance,
financial reporting, and compliance matters.  From 2004 through the present, Mr.
Marcovitch  has been a financial advisor for AgroFrut E.U., a company located in
Cali,  Columbia involved in fruit processing for nutriceutical operations.  From
July  2002  to  October  2003  Mr. Marcovitch was President of DDS Technologies,
Inc.,  and  became Chairman and Chief Executive Oficer of DDS Technologies, Inc.
in  October  2003 where he remained until April 2004.  DDS Technologies, Inc. is
an  international  venture capital and corporate management company with several
offices  in two countries.  From 2000 to 2001, Mr. Marcovitch was a Director and
Chairman  of  the  Board  of  Findex.com,  Inc.,  a  developer,  publisher  and
distributor  of  Christian  faith-based  software  products  to  individuals and
religious  organizations.  Mr.  Marcovitch is not presently a stockholder of the
Company.

     WILLIAM  L.  REALI,  64, will be elected as a Director of the Company.  Mr.
Reali  is  a  Certified  Public Accountant with the firm of Reali, Giampetro and
Scott  in Canfield, Ohio.  The firm provides accounting, tax and consulting to a
variety  of  business  clients.  Mr.  Reali's primary experience during the past
five  years  has  been  in  business  consulting.  Mr.  Reali is not presently a
stockholder  of  the  Company.

     RICHARD D. HORNIDGE, JR., 60, will be elected as a Director of the Company.
Mr.  Hornidge  is  a  long  time  and  respected  stockholder  of  Competitive
Technologies,  and  owner  of  62,000  shares of Competitive Technologies common
stock,  which is more shares than ANY of the existing management of the Company.
Since  February  2005,  Mr.  Hornidge  has been a tennis professional at Willows
Racquet  Club  in Byfield, Massachusetts.  From June 1984 through June 1989, Mr.
Hornidge  was  President  of Tennis Associates, a tennis employment agency.  Mr.
Hornidge was a program coordinator for Raytheon from 1973 through 1984, where he
was  involved  in  the  Patriot  Missile  test  equipment  program.

     JOEL M. EVANS, M.D., 46, will be elected as a Director of the Company.  Dr.
Evans  founded  The  Center  for Women's Health in Stamford, Connecticut in June
1996,  and since then has been its Director.  From November 1996 to present, Dr.
Evans  has been a lecturer and senior faculty member of The Center for Mind Body
Medicine  in  Washington, D.CDr. Evans has been featured in magazines as well as
interviewed  on  television  and radio shows across the country. Dr. Evans is an
Assistant  Clinical  Professor at the Albert Einstein College of Medicine in New
York  City  and  helped  create  a clinical study at Columbia University Medical



Center  for  use of the herb, black cohosh, in breast cancer. From November 2005
to  present,  Dr.  Evans  has been a member of the Scientific Advisory Board for
Metagenics  Incorporated,  a  nutritional  supplement  manufacturer.  Dr.  Evans
brings  key nutriceutical experience to the Company.  Dr. Evans is not presently
a  stockholder  of  the  Company.

     RALPH  S.  TORELLO,  68, will be elected as a Director of the Company.  For
the  past  five  years, Mr. Torello has been an independent financial consultant
advising  various  companies  on their financial strategies.  Included among the
companies  that  Mr.  Torello  has  performed  consulting services are Goodnight
Audio,  a full service recording studio, Patriot American Mortgage, a commercial
and  home  mortgage company, DDS Technologies, Inc., an organic waste processor,
Coit Medical, a medical accessory marketer and other miscellaneous companies and
individuals.  Mr.  Torello  is  not  presently  a  stockholder  of  the Company.

                               CERTAIN LITIGATION

     John  B.  Nano,  the  Committee's  nominee for Director President and Chief
Executive  Officer, was the President and Chief Executive Officer of Competitive
Technologies who was forced out seventeen months ago by the Board.  Mr. Nano has
a  lawsuit  pending  against  Competitive  Technologies.  In Nano v. Competitive
Technologies,  Inc., Docket No. 3:06-cv-00817, pending in United States District
Court  for the District of Connecticut, Mr. Nano seeks damages for the Company's
wrongful termination in retaliation for expressing concerns about allegations of
insider  trading, inappropriate corporate governance and lack of independence in
the  law firm selected to conduct an investigation of the issues he raised.  The
lawsuit  alleges  that  the  Company  violated  the Sarbanes-Oxley legislation's
whistleblower  protection.  In addition, Mr. Nano seeks compensatory damages for
the  Company's failure to honor his existing Employment Agreement or its failure
to honor the Separation Agreement and General Release that was negotiated by the
Board  as a substitute for it.  Competitive Technologies then sued Mr. Nano.  In
Competitive  Technologies,  Inc.  v.  Nano,  Docket No. FST-CV-065-40076245973S,
pending  in  Connecticut  Superior  Court,  Judicial  District  of  Stamford,
Competitive  Technologies  makes  numerous  claims  against  Mr. Nano, including
alleged  breach of contract, breach of his fiduciary duty, breach of his duty of
loyalty,  an alleged failure by him to turn over a director's fee paid to him by
another company (even though Mr. Nano's service on the other board was disclosed
and  Mr.  Nano's  receipt  of  a  director's  fee  was  approved  by Competitive
Technologies'  counsel).(1)  Mr. Nano believes  that  the lawsuit against him by
Competitive Technologies is retaliatory, that his actions have not been wrongful

- -------------------------
1 In its original complaint, Competitive Technologies also alleged that Mr. Nano
had improperly kept and disseminated proprietary company materials after being
terminated.  The company sought an injunction to enjoin Mr. Nano from possessing
the property or disseminating it to third parties.  The Company materials that
were allegedly wrongfully retained by Mr. Nano were retained at the time he was
terminated because of a misunderstanding.  This material was immediately
returned by Mr. Nano to Competitive Technologies, without him keeping any
copies, when the misunderstanding became apparent.  Because he had not kept the
materials wrongfully and had not disseminated them to anyone, Mr. Nano
voluntarily and readily entered into a stipulation that the injunction should
enter, thereby making that portion of the company's lawsuit moot.



and  that  Competitive  Technologies  has  incurred  no  provable  damages.

     Mr. Nano's damages for the breach of contract and his Sarbanes-Oxley claims
against Competitive Technologies have been calculated to exceed $5 million.  Mr.
Nano  was  not terminated for cause and he had accepted the Separation Agreement
offered  to  him by the Company, valued at approximately $1.4 million, primarily
for  salary  and bonuses under his agreements.  The Company did not honor either
Mr.  Nano's  Employment  Agreement  or  the  substituted  Separation  Agreement.

     If  Mr.  Nano's  slate  of  directors  were  to  succeed  in  this  proxy
solicitation,  Mr.  Nano  has  agreed to resolve these actions and enter into an
employment  agreement  on  roughly  the  same  terms  as  his  former employment
agreement.  Mr. Nano's employment agreement would provide for the same salary of
$350,000 and the same bonus based on performance with a target of 50% of salary.
The  resolution  of  his  lawsuit  would  include the compensation primarily for
salary  and  bonuses  to  which  Mr.  Nano  was entitled under his agreements of
approximately  $1.85  million  and  the  payment  of his legal fees of $650,000.

                                 OTHER BUSINESS

     The  Committee is not aware of any other matters that will be considered at
the  Annual  Meeting.  However, if any other matters are properly brought before
the  Annual  Meeting, the persons named on the enclosed BLUE proxy will vote the
shares  represented  by the BLUE proxy in accordance with their judgment on such
matters.

                               PROXY SOLICITATION

     The  cost  of  soliciting proxies by the Committee will be borne by it.  To
the extent legally permissible, the Committee intends to seek reimbursement from
Competitive Technologies for such cost.  The Committee does not currently intend
to  submit  approval of such reimbursement to a vote of Competitive Technologies
stockholders  at  a  subsequent  meeting.

     In  addition  to this initial solicitation of proxies by mail, email and/or
facsimile,  other  solicitation  may be made by members of the Committee without
additional  compensation  except  for  reimbursement of reasonable out-of-pocket
expenses.  The  Committee will pay to banks, brokers and other fiduciaries their
reasonable  charges and expenses incurred in forwarding proxy materials to their
principals and in obtaining authorization for execution of proxies.  Total costs
to  date  for solicitation of proxies by the Committee is approximately $25,000.
Total  estimated  costs  for  this  solicitation  will be approximately $50,000.




                             ADDITIONAL INFORMATION
                    CONCERNING COMPETITIVE TECHNOLOGIES, INC.

     To  the  best  knowledge  of  the  Committee, no one person or group is the
beneficial  owner  of  more  than  5%  of Competitive Technologies common stock.

     Competitive Technologies proxy statement filed on December 4, 2006 contains
information  with  respect  to  ownership  of  common stock by the Directors and
Officers  of  Competitive  Technologies.  Such  information  reflects  direct
ownership  of  a  total  of  156,430  shares  of common stock with an additional
375,250  subject  to  options.

     Proposals  by  security  holders  under  Rule  14a-8  to  be  presented  at
Competitive  Technologies'  2008  annual meeting must be received at Competitive
Technologies offices not later than 120 days before the mailing of the Company's
proxy statement for the 2008 annual meeting.  The Company in its Proxy Statement
has  anticipated  that  this  date  would  be  no  later  than  August  6, 2007.

     Copies  of this Proxy Statement and any additional solicitation material we
may  provide  or file is available on the website of the Securities and Exchange
Commission,  www.sec.gov.  On written request, we will provide without charge to
any record or beneficial owner of the Company's common or preferred stock a copy
of  such  Proxy  Statement  or  other  materials.  Written  requests  should  be
addressed  to:  Committee  to  Restore  Stockholder Value, c/o Cutler Law Group,
3206  West  Wimbledon  Drive,  Augusta,  GA  30909.  Copies  of  the  Company
Management's  proxy  statement, Annual Report on 10-K and other periodic reports
may  be  obtained  at  the  website  of  the Securities and Exchange Commission,
www.sec.gov.

PLEASE  SIGN,  DATE  AND  RETURN  PROMPTLY  THE  ENCLOSED BLUE PROXY CARD IN THE
ENCLOSED  ENVELOPE.  BY  SIGNING AND RETURNING THE ENCLOSED BLUE PROXY CARD, ANY
PROXY  PREVIOUSLY  SIGNED  BY  YOU  WILL  AUTOMATICALLY BE REVOKED.  IF YOU NEED
ASSISTANCE  IN  COMPLETING  YOUR  PROXY,  PLEASE  CALL JOHN DEREK ELWIN AT (561)
789-6449.


                   THE COMMITTEE TO RESTORE STOCKHOLDER VALUE


                         COMPETITIVE TECHNOLOGIES, INC.
            PROXY FOR ANNUAL MEETING OF STOCKHOLDERS-JANUARY 16, 2007
     THIS PROXY IS SOLICITED BY THE COMMITTEE TO RESTORE STOCKHOLDER VALUE IN
                                   OPPOSITION
TO MANAGEMENT'S NOMINEES FOR THE BOARD OF DIRECTORS OF COMPETITIVE TECHNOLOGIES,
                                      INC.

     The  undersigned  hereby  appoints  John B. Nano and M. Richard Cutler, and
each  of  them,  with  full  power  of  substitution  and  resubstitution,  the
attorney(s)  and  proxy(ies)  of  the  undersigned,  to  vote  all  shares  the
undersigned  may  be  entitled  to  vote,  with all powers the undersigned would
possess  if  personally  present  at  the  Annual  Meeting  of  Stockholders  of
Competitive  Technologies, Inc., to be held on Tuesday, January 16, 2007, and at
any  adjournments  or  postponements  thereof  on  the  following  matters,  as
instructed  below,  and,  in  their  discretion,  on  such  other matters as may
properly  come  before  the meeting, including any motion to adjourn or postpone
the meeting, all as more fully described in the Proxy Statement of The Committee
to  Restore  Stockholder  Value  ("Committee"),  dated  December  18,  2006.

1.   ELECTION  OF  DIRECTORS

[ ] For all nominees listed below                 [ ] WITHHOLD AUTHORITY to vote
    (except as indicated to the contrary below)       for all nominees

     JOHN B. NANO, BEN MARCOVITCH, WILLIAM L. REALI, JOEL M. EVANS, MD.,
     RICHARD D. HORNIDGE, JR. AND RALPH S. TORELLO

INSTRUCTION:  If you wish to withhold authority and preclude the proxy(ies) from
voting  for any individual nominees, write the name(s) of such nominee(s) in the
space  provided  below:

- -----------------------------------------------------------------------

2.   IN  THEIR  DISCRETION  THE  PROXIES NAMED ABOVE ARE AUTHORIZED TO VOTE UPON
SUCH  OTHER  MATTERS  AS  MAY  PROPERLY  COME  BEFORE  THE ANNUAL MEETING OR ANY
ADJOURNMENTS  OR  POSTPONEMENTS  THEREOF.

                                                 (Continued  on  reverse  side)

[REVERSE  SIDE  OF  PROXY  BELOW]

     This  proxy  when  properly  executed  will be voted in the manner directed
herein  by  the undersigned stockholder.  UNLESS OTHERWISE SPECIFIED, THIS PROXY
WILL  BE  VOTED  "FOR"  THE  ELECTION  OF THE COMMITTEE'S NOMINEES AS DIRECTORS.

     This  proxy  revokes  all  prior  proxies  given  by  the  undersigned.

                         Dated:____________________________________  200___

                         Signature:________________________________________

                         Signature  if
                         held  jointly_______________________________________

                         IMPORTANT:  Please  sign  exactly  as  name  appears on
                         your  stock certificate. Joint owners should each sign.
                         Executors,  Administrators,  Trustees,  etc.  should so
                         indicate  when  signing,  and  where  more  than one is
                         named,  a  majority  should  sign.

                         PLEASE  COMPLETE,  SIGN,  DATE  AND  MAIL THIS PROXY IN
                         THE  ENCLOSED  ENVELOPE.